Cleared Traditional

OPTICAL FRAME (HELEN,ARNOLD,VANA,BRUCE,MATT) (K910134) - FDA 510(k) Clearance

Class I Ophthalmic device.

K910134 · Kentucky Optical Co. · Ophthalmic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1991
Decision
65d
Days
Class 1
Risk

K910134 is an FDA 510(k) clearance for the OPTICAL FRAME (HELEN,ARNOLD,VANA,BRUCE,MATT). Classified as Frame, Spectacle (product code HQZ), Class I - General Controls.

Submitted by Kentucky Optical Co. (Louisville, US). The FDA issued a Cleared decision on March 15, 1991 after a review of 65 days - a notably fast clearance cycle.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.5842 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Kentucky Optical Co. devices

Submission Details

510(k) Number K910134 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 09, 1991
Decision Date March 15, 1991
Days to Decision 65 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
45d faster than avg
Panel avg: 110d · This submission: 65d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code HQZ Frame, Spectacle
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 886.5842
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.